Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02487485

Organisation Name: Yale University

Overal Status: Completed

Start Date: March 2016

Last Update: July 16, 2020

Lead Sponsor: Yale University

Brief Summary: The aim of the study is to provide insight into the impact of the immunosuppressant drug sirolimus, on the antidepressant effects of the prototypal rapid-acting antidepressant medication, ketamine.

Conditions:
  • Depression


Total execution time in seconds: 0.17276287078857